TTOO - T2 Biosystems receives Nasdaq extension to comply with bid price rule; company to transfer to Nasdaq Capital Market

T2 Biosystems (NASDAQ:TTOO) request for an extension until November 1, 2022, to regain compliance with minimum bid price requirement has been granted by the Nasdaq Hearings Panel. During the extension period, the company will continue to actively monitor the stock price while it considers the options available to it and to take action, if necessary and as deemed appropriate by the company’s board, to remedy the deficiency, including potentially effecting a reverse stock split.  The panel also approved the company’s request to transfer its listing of common stock from The Nasdaq Global Market to The Nasdaq Capital Market tier, effective June 13, 2022. The transfer is not expected to have any impact on trading in the company’s common stock, which will continue to trade under the symbol “TTOO.” Press Release

For further details see:

T2 Biosystems receives Nasdaq extension to comply with bid price rule; company to transfer to Nasdaq Capital Market